Page last updated: 2024-10-27

flecainide and Ovarian Neoplasms

flecainide has been researched along with Ovarian Neoplasms in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Taieb, D1
Chauveau, S1
Khamis, W1
de Montmollin, N1
Sesé, L1
Duchemann, B1
Nunes, H1
Uzunhan, Y1

Other Studies

1 other study available for flecainide and Ovarian Neoplasms

ArticleYear
[A case of systemic sclerosis].
    Revue des maladies respiratoires, 2020, Volume: 37, Issue:4

    Topics: Aged; Autoantibodies; Cystadenocarcinoma, Serous; Female; Flecainide; Humans; Lung Diseases, Interst

2020